Evaxion Biotech AS (EVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and ...

By Yahoo! Finance   |   1 month ago
Evaxion Biotech AS (EVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and ...

Expression Biotech handed back rights to the CMV vaccine, impacting production. The company plans to explore other production solutions. EVX-01 data to be presented at AACR includes biomarker and T cell data. ERV vaccines target cancers with high ERV burden.

Read More

Did you find this insightful?